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Richard T. Schumacher, founder
and member of the board of
directors of Boston Biomedica,
presents UNH staff scientist Heidi
Geiser with the company's first
Distinguished Scientist Award.
Geiser received the award for
work she has done extracting
biomolecules using BBI's patented
Pressure Cycling Technology
(PCT).






DURHAM, N.H. -- Heidi Geiser, a staff scientist in the University of New Hampshire's Center
for Structural Biology, was presented with Boston Biomedica's (BBI) first Distinguished
Scientist Award. Geiser received the award for work she has done extracting biomolecules using
BBI's patented Pressure Cycling Technology (PCT).
“This award recognizes the best research findings generated
over the past year using PCT,” said Richard T. Schumacher
`72, founder and member of the board of directors of Boston
Biomedica, headquartered in West Bridgewater, Mass.
“Heidi's work is the first strong indication we've had that
PCT has important applications in the exciting field of
proteomic [protein] research. We are very proud of her
achievement, and I am particularly proud that as an alumnus
I could return to UNH to present her this award.”
Last spring UNH became a test site for BBI's Barocycler
NEP2017, the instrument that is the backbone of Pressure
Cycling Technology. PCT is a novel process that subjects
samples to alternating cycles of low and high pressure,
allowing scientists to extract desired molecules from various
cells and tissues that are notoriously tough to crack.
Geiser has been working in collaboration with Vernon
Reinhold, the director of UNH's Center for Structural
Biology, to apply this technique to investigate the proteins,
glycoproteins, and glycosylated lipids that exist in C. elegans, a roundworm with a cellular
make-up that is, in many ways, like that of human cells.
“We've really appreciated being able to use PCT and the Barocycler,” said Geiser, whose project
was published in the Society for Glycobiology's journal, Glycobiology. “It has allowed us to
extract molecules in greater quantities than before, and to discover potentially new glycoproteins
—using PCT has become our standard procedure.”
Reinhold and Geiser's work is at the forefront of the emerging fields of proteomics and
glycomics—the study of molecular structure and their functional relationships are key to
developing new therapies and a healthier society.
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developing new therapies and a healthier society.
“Being able to read the genetic code for a protein isn't enough, because so much changes after a
gene is translated into a protein,” Professor Reinhold explained. “The glycosylation [adding of
sugar groups] to proteins is a universal process that takes place in all life forms. In people, when
this process malfunctions, it can create severe developmental problems. We believe that if we
reveal how glycosylation works in a simple model like C. elegans, we can lay the foundation for
understanding more complex models and developing therapeutic models for human disorders.”
Boston Biomedica provides products and services that have become global gold standards for
ensuring the accuracy of test results for diseases such as AIDS, hepatitis, West Nile and Lyme
Disease. Pressure Cycling Technology represents a new step in an additional new direction for
the company.
“This partnership with UNH has been critical for BBI,” said Kevin W. Quinlan `72, BBI's
president and COO. “As we develop new instruments and procedures in PCT, we will need to
continue to partner with scientists who are at the frontiers of their academic fields, such as Heide
Geiser, Vern Reinhold, and their colleagues.”
(Contributing writer: Dolores Leonard, UNH Publications)
